The Association for Human Pharmacology in the Pharmaceutical Industry London Meeting 2018: Brexit and Other Challenges in Early Phase Drug Development

• Váldodahkkit: Susan Reijntjes (Dahkki), Muna Albayaty (Dahkki), James Bush (Dahkki), Joseph Cheriyan (Dahkki), Anthea Cromie (Dahkki), Annelize Koch (Dahkki), Michael Hammond (Dahkki), Stuart Mair (Dahkki), Peter Scholes (Dahkki), Ulrike Lorch (Dahkki), Steffan Stringer (Dahkki), Jorg Taubel (Dahkki), Timothy C. Hardman (Dahkki)
• Materiálatiipa: Girji
• Almmustuhtton: Frontiers Media S.A., 2018-11-01T00:00:00Z.
• Fáttát: article
• Liŋkkat: Connect to this object online.

The Association for Human Pharmacology in the Pharmaceutical Industry (AHPPI) annual meeting focused on the changing face of early phase drug development and opened with a keynote speech concerning the revolution in pharmaceutical medicine over the last 30 years and the impact this has had on the wa...